X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2728) 2728
Book Review (990) 990
Publication (100) 100
Book Chapter (45) 45
Conference Proceeding (15) 15
Magazine Article (5) 5
Book / eBook (2) 2
Dissertation (2) 2
Newsletter (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1789) 1789
humans (1484) 1484
direct oral anticoagulants (1030) 1030
anticoagulants (969) 969
warfarin (882) 882
dabigatran (834) 834
direct thrombin inhibitor (763) 763
rivaroxaban (731) 731
venous thromboembolism (704) 704
atrial fibrillation (653) 653
hematology (628) 628
administration, oral (582) 582
anticoagulants - therapeutic use (580) 580
peripheral vascular disease (520) 520
male (472) 472
apixaban (443) 443
anticoagulants - administration & dosage (425) 425
female (424) 424
dabigatran etexilate (421) 421
atrial-fibrillation (410) 410
anticoagulants - adverse effects (405) 405
stroke (401) 401
pharmacology & pharmacy (394) 394
thromboembolism (381) 381
cardiac & cardiovascular systems (376) 376
prevention (357) 357
aged (351) 351
thrombin (323) 323
anticoagulation (305) 305
thrombosis (288) 288
middle aged (282) 282
risk factors (280) 280
atrial fibrillation - drug therapy (272) 272
hemorrhage - chemically induced (261) 261
bleeding (258) 258
pharmacokinetics (258) 258
treatment outcome (257) 257
direct oral anticoagulant (246) 246
management (243) 243
molecular-weight heparin (241) 241
safety (241) 241
direct thrombin inhibitors (239) 239
medicine, general & internal (236) 236
medicine & public health (235) 235
stroke prevention (234) 234
stroke - prevention & control (227) 227
blood coagulation - drug effects (225) 225
factor xa inhibitors (225) 225
analysis (220) 220
therapy (214) 214
surgery (212) 212
anticoagulants - pharmacology (211) 211
factor xa inhibitor (211) 211
factor-xa inhibitor (211) 211
deep-vein thrombosis (202) 202
oral anticoagulants (193) 193
adult (192) 192
antithrombotic therapy (191) 191
care and treatment (190) 190
pharmacodynamics (188) 188
atrial fibrillation - complications (187) 187
heparin (187) 187
risk (187) 187
aged, 80 and over (183) 183
patients (181) 181
edoxaban (178) 178
animals (177) 177
nonvalvular atrial-fibrillation (173) 173
drug therapy (172) 172
abridged index medicus (171) 171
prothrombin complex concentrate (167) 167
double-blind (166) 166
cardiology (164) 164
hemorrhage (158) 158
thrombin - antagonists & inhibitors (154) 154
internal medicine (149) 149
ximelagatran (145) 145
beta-alanine - analogs & derivatives (142) 142
anticoagulants - pharmacokinetics (139) 139
vitamin k - antagonists & inhibitors (139) 139
health aspects (138) 138
clinical trials (134) 134
enoxaparin (134) 134
coagulation (131) 131
pulmonary embolism (131) 131
cardiac arrhythmia (130) 130
reversal (129) 129
warfarin - therapeutic use (129) 129
medical research (127) 127
stroke - etiology (127) 127
thromboembolism - prevention & control (127) 127
dosage and administration (124) 124
vitamin k antagonists (124) 124
venous thromboembolism - drug therapy (122) 122
benzimidazoles - therapeutic use (119) 119
antithrombins - therapeutic use (118) 118
efficacy (118) 118
total hip-replacement (118) 118
coagulation assays (115) 115
mortality (115) 115
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2524) 2524
German (85) 85
French (75) 75
Spanish (46) 46
Japanese (23) 23
Russian (17) 17
Hungarian (7) 7
Italian (6) 6
Czech (4) 4
Polish (4) 4
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 1, pp. 27 - 28
In the pivotal phase III RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial, which involved 18,113 patients with atrial fibrillation... 
dabigatran | rivaroxaban | apixaban | direct oral anticoagulant | vitamin K antagonist | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | EFFICACY | SAFETY | RISK | ATRIAL-FIBRILLATION | WARFARIN | Myocardial infarction | Anticoagulants | Stroke | Mortality | Cardiovascular disease | Infarction | Health risk assessment
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2013, Volume 34, Issue 27, pp. 2094 - 2106
Journal Article
British Journal of Surgery, ISSN 0007-1323, 06/2014, Volume 101, Issue 7, pp. 742 - 749
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 20, pp. 2475 - 2484
Abstract Background Oral anticoagulation (OAC) with warfarin is underused for atrial fibrillation (AF). The availability of direct oral anticoagulants (DOACs)... 
Cardiovascular | Internal Medicine | direct oral anticoagulants | oral anticoagulation | atrial fibrillation | UNITED-STATES | ADHERENT ANTITHROMBOTIC TREATMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | PATTERNS | ASPIRIN | THERAPY | STROKE RISK | UNDERTREATMENT | WARFARIN USE | REGISTRY | INSIGHTS | United States - epidemiology | Stroke - prevention & control | Administration, Oral | Anticoagulants - classification | Atrial Fibrillation - drug therapy | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Male | Medication Therapy Management - standards | Warfarin - therapeutic use | Medication Therapy Management - organization & administration | Practice Patterns, Physicians' - trends | Practice Patterns, Physicians' - statistics & numerical data | Stroke - etiology | Atrial Fibrillation - epidemiology | Quality Improvement | Female | Registries | Aged | Health Services Accessibility - trends | Needs Assessment | Medical colleges | Warfarin | Atrial fibrillation | Analysis | Anticoagulants (Medicine) | Confidence intervals | Training | Cardiac arrhythmia | Anticoagulants | Fibrillation | Identification methods | Cardiovascular disease | Regression analysis | Drug therapy | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 12, pp. 1333 - 1351
Abstract Direct oral anticoagulants (DOACs) are approved for multiple thromboembolic disorders and provide advantages over existing agents. As with all... 
Cardiovascular | bleeding | management | pharmacology | dabigatran | rivaroxaban | apixaban | direct oral anticoagulant | edoxaban
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2019, Volume 73, Issue 25, pp. 3309 - 3311
In this issue of the Journal, Lee et al.(7)report their findings on the efficacy and safety of direct oral anticoagulants among individuals with atrial... 
atrial fibrillation | non-vitamin K oral antagonist | liver disease | cirrhosis | direct oral anticoagulant | warfarin | Hypertension | Anticoagulants | Cardiac arrhythmia | Enzymes | Stroke | Liver diseases | Laboratories | Metabolism | Drug dosages
Journal Article
Journal Article